Loading...

World-Class Retina Care. Community-Based Caring.

Dr. Abbey Presented at the American Academy of Ophthalmology 2022 Meeting

Posted On October 3, 2022 / By / Posted in Blog

Dr. Abbey Presented at the American Academy of Ophthalmology 2022 Meeting

Over the weekend, Texas Retina Associates’ Ashkan M. Abbey, MD, taught a course titled “Secondary Intraocular Lens (IOL) Techniques for Retina Specialists” at the American Academy of Ophthalmology (AAO) 2022 meeting in Chicago,

read more
Posted On September 21, 2022 / By / Posted in Blog

Dr. Abbey Presented National Webinar on Treatment of Patients with Diabetic Macular Edema and 20/50 or Worse Vision

On Monday, September 19, 2022, Texas Retina Associates’ Ashkan M. Abbey, MD, delivered a webinar titled, “Does Treatment Selection Matter in Patients with Diabetic Macular Edema and 20/50 or Worse Vision?” Dr. Abbey discussed

read more
Posted On August 8, 2022 / By / Posted in Blog

Texas Retina Associates First in the Country to Dose a Patient in the DAVIO 2 Clinical Trial

Texas Retina Associates is honored to have randomized the first patient in EyePoint Pharmaceuticals’ Phase 2 “Durasert and Vorolanib in Ophthalmology 2” (DAVIO 2) clinical trial of EYP-1901 for patients with wet macular

read more
Posted On July 14, 2022 / By / Posted in Blog

Dr. Abbey Presents at the American Society of Retina Specialists 2022 Annual Meeting

Texas Retina Associates’ Ashkan M. Abbey, MD,  is presenting this week at the 40th Annual Scientific Meeting of the American Society of Retina Specialists (ASRS) in New York City. ASRS is the

read more
Posted On June 14, 2022 / By / Posted in Blog

Dr. Abbey’s Research Featured in New Retina Podcast

The medical journal Retina recently released a podcast featuring research by Texas Retina Associates’ Ashkan M. Abbey, MD, on clinical outcomes and surgical technique in transconjunctival sutureless intrascleral fixation of intraocular lenses

read more
Posted On June 1, 2022 / By / Posted in Blog

Dr. Abbey Presented Preliminary Findings of a Diabetic Macular Edema Clinical Trial at the Retina World Congress

Texas Retina Associates’ Ashkan M. Abbey, MD served as an invited faculty member for the Retina World Congress held May 12-15, 2022, in Fort Lauderdale, Florida. This global physician meeting featured presentations

read more
Posted On April 19, 2022 / By / Posted in Blog

Dr. Abbey Spoke About Complications of a Compounded Medication Used in “Dropless” Cataract Surgery at the Vit-Buckle Society (VBS) Annual Meeting

Texas Retina Associates’ Ashkan M. Abbey, MD, presented “Complications of Compounded Moxifloxacin-Triamcinolone” at the 10th Annual Meeting of the Vit-Buckle Society (VBS) held March 24 – 26, 2022, in Las Vegas. He

read more
Posted On April 4, 2022 / By / Posted in Blog

Meet Our Dallas Clinical Research Coordinators

Karen Duignan, Sally Arceneaux, Ashley Hughes and Jessica Flores serve as our clinical research coordinators for Dallas. They assist patients with their enrollment and participation in our wide variety of clinical trials

read more
Posted On November 15, 2021 / By / Posted in Blog

Dr. Abbey Discusses COED Clinical Trial for Diabetic Macular Edema in New Video

In a new video published on Modern Retina, Texas Retina Associates’ Ashkan M. Abbey, MD, discusses the COED clinical trial which is testing the efficacy of combining steroid and anti-VEGF therapy in

read more
Posted On October 19, 2021 / By / Posted in Blog

Dr. Abbey to Speak at Upcoming Retina World Congress Medical Education Event

On October 24, 2021, Texas Retina Associates’ Ashkan M. Abbey, MD, will serve on a distinguished panel of presenters from across the country for a Retina World Congress continuing medical education (CME)

read more